Cresset Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,633
| Closed | -$861K | – | 1098 |
|
|
2021
Q1 | $861K | Sell |
5,633
-1,514
| -21% | -$231K | 0.01% | 334 |
|
|
2020
Q4 | $1.12M | Sell |
7,147
-9,882
| -58% | -$1.54M | 0.02% | 224 |
|
|
2020
Q3 | $1.95M | Sell |
17,029
-3,578
| -17% | -$409K | 0.04% | 168 |
|
|
2020
Q2 | $2.31M | Buy |
+20,607
| New | +$2.31M | 0.05% | 133 |
|
|
2019
Q2 | – | Sell |
-633
| Closed | -$86K | – | 1942 |
|
|
2019
Q1 | $86K | Sell |
633
-29
| -4% | -$3.94K | ﹤0.01% | 607 |
|
|
2018
Q4 | $64K | Buy |
+662
| New | +$64K | ﹤0.01% | 424 |
|